Journal of Sickle Cell Disease

Oxford University Press

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Journal of Sickle Cell Disease is an open-access journal published by Oxford University Press in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,500 USD. Declared review time at DOAJ: 15 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Oxford University Press
ISSN
3029-0473
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
2,500 USD
Articles in DOAJ
0
Declared review time
15 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2026-01-20
Indexing
DOAJ
APC
2,500 USD
Declared review time (DOAJ)
15 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

0

Average review time (journal-declared via DOAJ)

15weeks

Works in OpenAlex

267

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

3

i10-index

0

From OpenAlex open data (CC0).

Editorial & policy11
Added to DOAJ
2026-01-20
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
LOCKSS
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
31%
ORCID iDs in current deposits
32%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
Journal of sickle cell disease
Source type
journal
NLM unique ID (PubMed)
9918991895506676
Classification2

Subjects (DOAJ)

Science: Biology (General): Genetics

LCC codes

QH426-470

Subject areas

  • Hemoglobinopathies and Related Disorders
  • Hemoglobinopathies and Related Disorders
  • Iron Metabolism and Disorders
  • Iron Metabolism and Disorders
  • Blood groups and transfusion
  • Blood groups and transfusion
  • Hemoglobin structure and function
  • Hemoglobin structure and function
Show all subjects (50)
  • Folate and B Vitamins Research
  • Folate and B Vitamins Research
  • Adolescent and Pediatric Healthcare
  • Adolescent and Pediatric Healthcare
  • Prenatal Screening and Diagnostics
  • Bone and Joint Diseases
  • Bone and Joint Diseases
  • Prenatal Screening and Diagnostics
  • Erythrocyte Function and Pathophysiology
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Food Security and Health in Diverse Populations
  • Erythrocyte Function and Pathophysiology
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Food Security and Health in Diverse Populations
  • HIV/AIDS Research and Interventions
  • HIV/AIDS Research and Interventions
  • Neonatal Health and Biochemistry
  • Neonatal Health and Biochemistry
  • Epilepsy research and treatment
  • Acute Myeloid Leukemia Research
  • Psychosomatic Disorders and Their Treatments
  • Race, Genetics, and Society
  • Biotechnology and Related Fields
  • Global Health and Surgery
  • Psychosomatic Disorders and Their Treatments
  • Epilepsy research and treatment
  • Acute Myeloid Leukemia Research
  • Race, Genetics, and Society
  • Global Health and Surgery
  • Biotechnology and Related Fields
  • Childhood Cancer Survivors' Quality of Life
  • Epigenetics and DNA Methylation
  • Neurogenetic and Muscular Disorders Research
  • Chronic Disease Management Strategies
  • Pain Management and Opioid Use
  • Childhood Cancer Survivors' Quality of Life
  • Epigenetics and DNA Methylation
  • Neurogenetic and Muscular Disorders Research
  • Chronic Disease Management Strategies
  • Pain Management and Opioid Use
  • Palliative Care and End-of-Life Issues
  • Palliative Care and End-of-Life Issues

Keywords (DOAJ)

  • sickle cell disease
  • sickle cell trait
  • genetic modifiers
  • holistic disease
  • translational research

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: